Cristani A, Pentore R, Cioni G, Mussini C, Grandi S, Ventura E
Recenti Prog Med. 1989 May;80(5):233-6.
107 (8.2%) of 1297 patients with liver cirrhosis admitted to our Clinic between 1980 and 1987 had hepatocellular carcinoma (HCC). This disorder was more frequent in patients with liver cirrhosis of dual etiology, alcoholic and post-hepatitic (9.9%), than in those with liver cirrhosis of unknown (7.82%), alcoholic (9.35%) or post-hepatitic (5.16%) etiology. The mean age of the patients with HCC of dual etiology (51.2 years) was significantly lower than that of the other three groups (61.0, 62.0 and 64.5 years, respectively; p less than 0.001). The conclusion is that in patients with liver cirrhosis of dual etiology the onset of HCC is frequent and precocious. This fact must be considered in epidemiological studies, in the prognosis and in the clinical management of the patient since early diagnosis is of importance in deciding therapy.
1980年至1987年间,我院收治的1297例肝硬化患者中,有107例(8.2%)发生肝细胞癌(HCC)。这种疾病在酒精性和肝炎后双重病因的肝硬化患者中更为常见(9.9%),高于病因不明(7.82%)、酒精性(9.35%)或肝炎后(5.16%)的肝硬化患者。双重病因的HCC患者平均年龄(51.2岁)显著低于其他三组(分别为61.0岁、62.0岁和64.5岁;p<0.001)。结论是,在双重病因的肝硬化患者中,HCC的发生频繁且较早。在流行病学研究、预后评估以及患者的临床管理中都必须考虑这一事实,因为早期诊断对于决定治疗方案至关重要。